Format
Sort by
Items per page

Send to

Choose Destination

Best matches for alzheimer's tomm40:

Search results

Items: 1 to 20 of 146

1.

Analysis of cognitive performance and polymorphisms of SORL1, PVRL2, CR1, TOMM40, APOE, PICALM, GWAS_14q, CLU, and BIN1 in patients with mild cognitive impairment and cognitively healthy controls.

Cruz-Sanabria F, Bonilla-Vargas K, Estrada K, Mancera O, Vega E, Guerrero E, Ortega-Rojas J, Mahecha María F, Romero A, Montañés P, Celeita V, Arboleda H, Pardo R.

Neurologia. 2018 Nov 29. pii: S0213-4853(18)30198-1. doi: 10.1016/j.nrl.2018.07.002. [Epub ahead of print] English, Spanish.

2.

Longer TOMM40 poly-T variants associated with higher FDDNP-PET medial temporal tau and amyloid binding.

Siddarth P, Burggren AC, Merrill DA, Ercoli LM, Mahmood Z, Barrio JR, Small GW.

PLoS One. 2018 Dec 5;13(12):e0208358. doi: 10.1371/journal.pone.0208358. eCollection 2018.

3.

Underappreciated Roles of the Translocase of the Outer and Inner Mitochondrial Membrane Protein Complexes in Human Disease.

Heinemeyer T, Stemmet M, Bardien S, Neethling A.

DNA Cell Biol. 2019 Jan;38(1):23-40. doi: 10.1089/dna.2018.4292. Epub 2018 Nov 27.

PMID:
30481057
4.

Independent associations of TOMM40 and APOE variants with body mass index.

Kulminski AM, Loika Y, Culminskaya I, Huang J, Arbeev KG, Bagley O, Feitosa MF, Zmuda JM, Christensen K, Yashin AI; Long Life Family Study Research Group.

Aging Cell. 2018 Nov 21:e12869. doi: 10.1111/acel.12869. [Epub ahead of print]

5.

Biothiols and oxidative stress markers and polymorphisms of TOMM40 and APOC1 genes in Alzheimer's disease patients.

Prendecki M, Florczak-Wyspianska J, Kowalska M, Ilkowski J, Grzelak T, Bialas K, Wiszniewska M, Kozubski W, Dorszewska J.

Oncotarget. 2018 Oct 16;9(81):35207-35225. doi: 10.18632/oncotarget.26184. eCollection 2018 Oct 16.

6.

The Molecular and Neuropathological Consequences of Genetic Risk for Alzheimer's Dementia.

Tasaki S, Gaiteri C, Mostafavi S, De Jager PL, Bennett DA.

Front Neurosci. 2018 Oct 8;12:699. doi: 10.3389/fnins.2018.00699. eCollection 2018.

7.

Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.

Ramos de Matos M, Ferreira C, Herukka SK, Soininen H, Janeiro A, Santana I, Baldeiras I, Almeida MR, Lleó A, Dols-Icardo O, Alcolea D, Benussi L, Binetti G, Paterlini A, Ghidoni R, Nacmias B, Meulenbroek O, van Waalwijk van Doorn LJC, Kuiperi HBJ, Hausner L, Waldemar G, Simonsen AH, Tsolaki M, Gkatzima O, Resende de Oliveira C, Verbeek MM, Clarimon J, Hiltunen M, de Mendonça A, Martins M.

J Alzheimers Dis. 2018;66(2):639-652. doi: 10.3233/JAD-180512.

PMID:
30320580
8.

Genome-Wide Association and Mechanistic Studies Indicate That Immune Response Contributes to Alzheimer's Disease Development.

Liu C, Chyr J, Zhao W, Xu Y, Ji Z, Tan H, Soto C, Zhou X; Alzheimer’s Disease Neuroimaging Initiative.

Front Genet. 2018 Sep 24;9:410. doi: 10.3389/fgene.2018.00410. eCollection 2018.

9.

Mitochondrial accumulation of amyloid β (Aβ) peptides requires TOMM22 as a main Aβ receptor in yeast.

Hu W, Wang Z, Zheng H.

J Biol Chem. 2018 Aug 17;293(33):12681-12689. doi: 10.1074/jbc.RA118.002713. Epub 2018 Jun 20.

PMID:
29925587
10.

Genetic Risk for Age-Related Cognitive Impairment Does Not Predict Cognitive Performance in Middle Age.

Korthauer LE, Awe E, Frahmand M, Driscoll I.

J Alzheimers Dis. 2018;64(2):459-471. doi: 10.3233/JAD-171043.

PMID:
29865048
11.

Apolipoprotein E region molecular signatures of Alzheimer's disease.

Kulminski AM, Huang J, Wang J, He L, Loika Y, Culminskaya I.

Aging Cell. 2018 May 23:e12779. doi: 10.1111/acel.12779. [Epub ahead of print]

12.

GWAS on family history of Alzheimer's disease.

Marioni RE, Harris SE, Zhang Q, McRae AF, Hagenaars SP, Hill WD, Davies G, Ritchie CW, Gale CR, Starr JM, Goate AM, Porteous DJ, Yang J, Evans KL, Deary IJ, Wray NR, Visscher PM.

Transl Psychiatry. 2018 May 18;8(1):99. doi: 10.1038/s41398-018-0150-6.

13.

DNA methylation in the APOE genomic region is associated with cognitive function in African Americans.

Liu J, Zhao W, Ware EB, Turner ST, Mosley TH, Smith JA.

BMC Med Genomics. 2018 May 8;11(1):43. doi: 10.1186/s12920-018-0363-9.

14.

The effects of the TOMM40 poly-T alleles on Alzheimer's disease phenotypes.

Chiba-Falek O, Gottschalk WK, Lutz MW.

Alzheimers Dement. 2018 May;14(5):692-698. doi: 10.1016/j.jalz.2018.01.015. Epub 2018 Mar 7.

PMID:
29524426
15.

Corrigendum to "The Biological Foundation of the Genetic Association of TOMM40 with Late-onset Alzheimer's disease" [Biochim. Biophys. Acta 1863/11 (2017) 2973-2986].

Zietlow K, Charalambous L, Ng I, Gagrani S, Mihovilovic M, Luo S, Rock DL, Saunders A, Roses AD, Kirby Gottschalk W.

Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt A):1216. doi: 10.1016/j.bbadis.2018.01.017. Epub 2018 Jan 31. No abstract available.

PMID:
29395737
16.

DNA methylation of TOMM40-APOE-APOC2 in Alzheimer's disease.

Shao Y, Shaw M, Todd K, Khrestian M, D'Aleo G, Barnard PJ, Zahratka J, Pillai J, Yu CE, Keene CD, Leverenz JB, Bekris LM.

J Hum Genet. 2018 Apr;63(4):459-471. doi: 10.1038/s10038-017-0393-8. Epub 2018 Jan 25.

PMID:
29371683
17.

Genetic Biomarkers on Age-Related Cognitive Decline.

Lin CH, Lin E, Lane HY.

Front Psychiatry. 2017 Nov 21;8:247. doi: 10.3389/fpsyt.2017.00247. eCollection 2017. Review.

18.

Characterization of APOE and TOMM40 allele frequencies in the Japanese population.

Nishimura A, Nonomura H, Tanaka S, Yoshida M, Maruyama Y, Aritomi Y, Saunders AM, Burns DK, Lutz MW, Runyan G, Lai E, Budur K, Roses AD.

Alzheimers Dement (N Y). 2017 Sep 6;3(4):524-530. doi: 10.1016/j.trci.2017.07.003. eCollection 2017 Nov.

19.

Hidden heterogeneity in Alzheimer's disease: Insights from genetic association studies and other analyses.

Yashin AI, Fang F, Kovtun M, Wu D, Duan M, Arbeev K, Akushevich I, Kulminski A, Culminskaya I, Zhbannikov I, Yashkin A, Stallard E, Ukraintseva S.

Exp Gerontol. 2018 Jul 1;107:148-160. doi: 10.1016/j.exger.2017.10.020. Epub 2017 Oct 26.

PMID:
29107063
20.

Global analysis of ginsenoside Rg1 protective effects in β-amyloid-treated neuronal cells.

Shim JS, Song MY, Yim SV, Lee SE, Park KS.

J Ginseng Res. 2017 Oct;41(4):566-571. doi: 10.1016/j.jgr.2016.12.003. Epub 2016 Dec 8.

Supplemental Content

Loading ...
Support Center